May 18, 2025 05:44 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Centre picks Shashi Tharoor to head all-party delegation for 'exposing' Pak-backed terrorism globally | Rape convict, survivor express willingness to get married; exchange flowers in Supreme Court | 'Are nukes safe with irresponsible and rogue nation like Pakistan?': Rajnath Singh questions world | 'Go and apologise': Supreme Court slams Madhya Pradesh minister over remark against Colonel Sofiya Qureshi | 'Can timelines be imposed?': President Murmu's question to Supreme Court on Tamil Nadu verdict | 'Had Indira Gandhi been alive, I would've asked her why PoK was not taken back in Simla Agreement': Himanta Biswa Sarma | India's stand demanding vacation of Pak-occupied Kashmir unchanged: MEA | PM Modi visits Adampur Air Base days after Operation Sindoor | Jammu and Kashmir: Three Lashkar-e-Taiba terrorists killed in encounter with security forces in Shopian | US: Two Indian students die in road mishap in Pennsylvania
Adar Poonawalla
Adar Poonawalla Twitter page

Will take 4-5 years until everyone gets COVID-19 vaccine, says Serum Institute of India CEO Adar Poonawalla 

| @indiablooms | Sep 14, 2020, at 11:40 pm

Pune: Adar Poonawalla, chief executive of the Serum Institute of India, has said it will take four to five years until everyone gets the COVID-19 vaccine on this planet.

He told the Financial Times that pharmaceutical companies were not increasing production capacity quickly enough to vaccinate the global population in less time.

“It’s going to take four to five years until everyone gets the vaccine on this planet,” said Poonawalla, who estimated that if the Covid-19 shot is a two-dose vaccine — such as measles or rotavirus — the world will need 15bn doses.  

Based in the western Indian city of Pune, the family-run Serum Institute has partnered with five international pharmaceutical firms, including AstraZeneca and Novavax, to develop a Covid-19 vaccine and committed to produce 1bn doses, of which it has pledged half to India. The company may also partner with Russia’s Gamaleya Research Institute to manufacture the Sputnik vaccine, reports the newspaper.

India is one of the nations in the world that has registered a high number of COVID-19 cases for the past several months.

The virus is believed to have originated from China.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.
Close menu